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Abstract
Investigations on the relationship between sepsis, brain dys-
function, and cerebral perfusion are methodologically very difficult
to perform. It is important to interpret the results of such studies in
view of our limited ability to diagnose and quantify brain dys-
function and to consider our limited understanding of the
mechanisms that lead to or are associated with brain dysfunction in
sepsis.
Thees and colleagues [1] performed an interesting study in a
group of patients who are difficult to investigate. They
measured cerebral haemodynamics and CO2 reactivity in 10
mechanically ventilated patients with sepsis syndrome. They
report normal global cerebral blood flow (CBF) and also
normal responses to a decrease in the arterial partial
pressure of CO2 assessed as critical closing pressure and
CO2 reactivity. CO2 reactivity has previously been
investigated in similar groups of patients but with inconsistent
results. Bowton and colleagues [2] and Matta and Stow [3]
found normal values, Terborg and colleagues [4] found
impaired CO2 reactivity, and Bowie and colleagues [5]
reported values ranging from reduced to exaggerated CO2
responses.
Brain dysfunction is a serious complication of sepsis. The
severity of septic encephalopathy or sepsis-associated
delirium (SAD) [6] is correlated with the global severity of
sepsis and has been reported to be an independent predictor
of death [7]. The mechanisms leading to SAD are not
completely understood and include reduced CBF, disruption
of the blood-brain barrier and cerebral oedema arising from
the action of inflammatory mediators on the cerebrovascular
endothelium, impaired astrocyte function, and neuronal
degeneration [8]. Recent experimental work suggests that
the complement cascade [9] and tumour necrosis factor [10]
are key mediators of SAD. As a ‘downstream’ phenomenon of
both, these reports document an aquaporin-4 overexpression
with an increase in brain water content and apoptotic
neuronal cell death.
Based on the data presented by Thees and colleagues, I
would like highlight some of the difficulties that make clinical
research on SAD such a challenge. The first challenge is to
identify and possibly quantify brain dysfunction in patients
with sepsis. In my opinion, it is very likely that the majority of
the patients investigated by Thees and colleagues had SAD;
however, the presented data are inconclusive. The
electroencephalogram (EEG) was abnormal in all patients.
Propofol and sufentanil were used to achieve a Ramsey score
of 3, doses are not reported, and it is conceivable that the
sedatives interfered with the EEG interpretation. EEG is just
one possible aid to diagnose SAD and is certainly not
specific for this entity. Seven of the patients had a computed
tomography (CT) scan, all of which were normal. This finding
is difficult to interpret as CT is perhaps not the best tool to
investigate patients with SAD. A recent magnetic resonance
imaging study documented lesions in seven of nine patients
with septic shock and brain dysfunction [11]. Two had
ischaemic lesions and five had findings corresponding to
vasogenic oedema, probably reflecting blood-brain barrier
breakdown, a finding that is compatible with experimental
research [9,10]. Upon neurological examination 3 days after
discontinuation of sedation, four of the eight surviving
patients had psychotic symptoms, none was oriented in
regard to time and location, and five were disoriented in
regard to person. A validated instrument to diagnose delirium
was not used. Ideally, SAD should be diagnosed during the
daily interruption of sedation. However, this is not always
possible and recently a concept incorporating clinical testing,
blood markers of neuronal or astrocyte damage (such as
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neuron-specific enolase or S-100β), electrophysiology, and
possibly imaging has been proposed [6]. However, such a
concept has not been validated, and in the absence of a gold
standard, diagnosis of SAD will remain a challenge.
A second question that is prompted by the work of Thees and
colleagues is whether we should expect global CBF and CO2
reactivity to be disturbed in SAD. Or if disturbed cerebral
perfusion or vascular reactivity is present, is it the cause or
consequence of the SAD? An early study found low CBF
independent of arterial pressure in septic patients [2]. In a
retrospective observation, hypotension was the only predictor
of SAD [12], suggesting that low CBF and consecutive
ischaemia play an important role in the development of SAD.
In that study [1], the patients were carefully stabilized and
CBF was in the normal range. CBF values are expected to
vary considerably due to sedation and the age of the included
patients, and in my opinion it is impossible to define a ‘normal’
CBF range for such a group of patients. Moreover, ischaemic
changes in relatively small brain regions could be responsible
for the development of SAD [11,13] and would not be
detected with the methods used. Therefore, in my opinion,
the fact that global CBF was normal at the time of measure-
ment does not add to our understanding of SAD. What can
CO2 reactivity tell us? CO2 reactivity is a relatively robust
mechanism and in adults is independent of the endothelium
[14]. Therefore, one could speculate that, in analogy to
traumatic brain injury, severe brain dysfunction is necessary
to disturb CO2 reactivity. The action of inflammatory
mediators on the endothelium has been proposed as an
important element in the development of SAD. Endothelial
dysfunction would probably affect pressure autoregulation
rather than CO2 reactivity. However, the recent literature on
autoregulation in patients with sepsis is as inconclusive as
that on CO2 reactivity [3,15]. Nevertheless, assuming that
disturbed cerebrovascular reactivity is a consequence rather
than the cause of SAD, it could inform on the extent of the
effect of inflammatory mediators on the brain.
Investigations addressing SAD will remain difficult due to the
problem of correctly identifying and quantifying this entity.
The value of monitoring cerebral perfusion and cerebro-
vascular reactivity in this setting remains to be defined.
However, further experimental and clinical investigations on
SAD are important and carefully controlled studies like the
work by Thees and colleagues are to be encouraged.
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